Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone

被引：0
|
作者：
Oliver Kummer
Felix Hammann
Claudine Moser
Olivier Schaller
Jürgen Drewe
Stephan Krähenbühl
机构：
[1] University Hospital,Division of Clinical Pharmacology and Toxicology, Department of Biomedicine
[2] Mundipharma Medical Company,undefined
来源：
European Journal of Clinical Pharmacology | 2011年 / 67卷
关键词：
Oxycodone; Ketoconazole; Paroxetine; Drug interactions; Pharmacokinetics; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：63 / 71
页数：8
相关论文
共 50 条
  • [1] Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
    Kummer, Oliver
    Hammann, Felix
    Moser, Claudine
    Schaller, Olivier
    Drewe, Juergen
    Kraehenbuehl, Stephan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (01) : 63 - 71
  • [2] Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone
    Gronlund, Juha
    Saari, Teijo I.
    Hagelberg, Nora M.
    Neuvonen, Pertti J.
    Olkkola, Klaus T.
    Laine, Kari
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (01) : 78 - 87
  • [3] The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone
    Samer, C. F.
    Daali, Y.
    Wagner, M.
    Hopfgartner, G.
    Eap, C. B.
    Rebsamen, M. C.
    Rossier, M. F.
    Hochstrasser, D.
    Dayer, P.
    Desmeules, J. A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (04) : 907 - 918
  • [4] Miconazole Oral Gel Increases Exposure to Oral Oxycodone by Inhibition of CYP2D6 and CYP3A4
    Gronlund, Juha
    Saari, Teijo I.
    Hagelberg, Nora
    Neuvonen, Pertti J.
    Olkkola, Klaus T.
    Laine, Kari
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) : 1063 - 1067
  • [5] In vitro Inhibition of Human CYP1A2, CYP2D6, and CYP3A4 by Six Herbs Commonly Used in Pregnancy
    Langhammer, Astrid Jordet
    Nilsen, Odd Georg
    PHYTOTHERAPY RESEARCH, 2014, 28 (04) : 603 - 610
  • [6] The In Vitro Inhibition of Human CYP1A2, CYP2D6 and CYP3A4 by Tetrahydropalmatine, Neferine and Berberine
    Zhao, Yong
    Hellum, Bent Havard
    Liang, Aihua
    Nilsen, Odd Georg
    PHYTOTHERAPY RESEARCH, 2012, 26 (02) : 277 - 283
  • [7] Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes
    Byeon, Ji-Yeong
    Lee, Yun Jeong
    Kim, Young-Hoon
    Kim, Se-Hyung
    Lee, Choong-Min
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    Choi, Chang-Ik
    ARCHIVES OF PHARMACAL RESEARCH, 2018, 41 (05) : 564 - 570
  • [8] Systematic and Quantitative Assessment of the Effect of Chronic Kidney Disease on CYP2D6 and CYP3A4/5
    Yoshida, K.
    Sun, B.
    Zhang, L.
    Zhao, P.
    Abernethy, D. R.
    Nolin, T. D.
    Rostami-Hodjegan, A.
    Zineh, I.
    Huang, S-M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (01) : 75 - 87
  • [9] Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes
    Ji-Yeong Byeon
    Yun Jeong Lee
    Young-Hoon Kim
    Se-Hyung Kim
    Choong-Min Lee
    Jung-Woo Bae
    Choon-Gon Jang
    Seok-Yong Lee
    Chang-Ik Choi
    Archives of Pharmacal Research, 2018, 41 : 564 - 570
  • [10] The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites
    Chapron, Brian D.
    Dinh, Jean C.
    Toren, Paul C.
    Gaedigk, Andrea
    Leeder, J. Steven
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (11) : 1113 - 1120
12345